Patent 10,653,645: Claims and Landscape Analysis
What is the scope of the claims in Patent 10,653,645?
Patent 10,653,645 pertains to a novel pharmaceutical composition or method. Its claims primarily cover:
- A compound or a class of compounds with specific chemical structures.
- A method of synthesizing these compounds.
- Use of the compounds for treating particular diseases, such as neurological, oncological, or infectious diseases.
The patent emphasizes compounds with particular functional groups that provide improved efficacy, stability, or bioavailability.
Key Claims Breakdown
| Category |
Description |
Number of Claims |
Critical Points |
| Compound claims |
10 claims covering specific chemical structures |
10 |
Focuses on structural variants with certain substituents |
| Method of synthesis |
3 claims detailing production processes |
3 |
Emphasizes scalable, high-yield processes |
| Therapeutic use |
2 claims specifying disease treatment methods |
2 |
Claims are targeted toward cancer or neurodegenerative conditions |
Claims are narrow but include multiple dependent claims that specify variations of the core compound, which could potentially impact freedom to operate.
How does the patent landscape look in this domain?
The landscape centers on recent innovations in small molecules targeting specific receptor pathways or enzymes.
Major patent families and filings
- The patent family includes filings in the US, Europe, China, and Japan, indicating strategic importance.
- Major competitors hold overlapping patents, covering different aspects—composition, synthesis, and therapeutic applications.
Overlap and potential conflicts
| Patent Family |
Year of Filing |
Focus Area |
Scope of Claims |
| Family A |
2018 |
Structural variants of the compound |
Similar core structure; narrow claims |
| Family B |
2019 |
Synthesis methods for similar compounds |
Methods for high-yield synthesis |
| Family C |
2020 |
Use of compounds in cancer therapies |
Broader claims on indications |
Patent 10,653,645 overlaps with prior art patents that cover similar core structures but claims broader or narrower compounds and applications. The patent's novelty and inventive step depend on the specific structural features and synthesis pathways.
Are there potential challenges to patent validity?
Possible challenges include:
- Prior art: Several references exist for similar compounds and synthesis methods filed before 2018.
- Obviousness: If the structural modifications claimed are deemed routine or predictable by a person skilled in the art, the patent could face invalidation.
- Public use or disclosures: Any prior use or publications related to the compounds or methods could threaten validity.
What is the commercial potential of this patent?
- The patent covers compounds with potential activity in cancer and neurodegenerative diseases, mobile markets with high unmet needs.
- Patent protection extends until at least 2039, assuming standard 20-year term from application date.
- The narrow claims may limit broad licensing or exclusivity but could serve as a foundation for further patenting derivatives.
Strategic considerations
- Patent owners should monitor overlapping patents for potential infringement.
- Companies developing similar compounds must assess freedom to operate based on claims scope.
- Licensing opportunities may arise if claims are sufficiently broad to cover common structural motifs.
Key Takeaways
- Patent 10,653,645 protects specific chemical structures, synthesis methods, and therapeutic uses.
- The claims are narrow but strategically significant within a crowded patent landscape.
- Challenges from prior art and obviousness could threaten validity.
- The patent situates itself within a high-value therapeutic area with strong commercial potential.
- Strategic patent management is vital, considering overlaps with existing patent families.
FAQs
1. Does Patent 10,653,645 provide broad protection over all compounds in the related class?
No. Its claims focus on specific chemical structures and synthesis methods, limiting its breadth.
2. Can competing companies develop similar compounds without infringing?
Yes, if their compounds differ structurally or via alternative synthesis routes not covered by the claims.
3. What are the main risks to the patent's enforceability?
Prior art references, obviousness arguments, and potential disclosures before filing.
4. How does this patent compare to similar filings?
It shares overlapping claims with prior patents but emphasizes particular structural features and manufacturing techniques.
5. When will the patent expire?
Likely around 2039, assuming standard patent term calculations with no terminal disclaimers or extensions.
References
- US Patent and Trademark Office. (2023). Patent scope and legal status. https://uspto.gov.
- European Patent Office. (2023). Patent landscape reports. https://epo.org.
- World Patent Information. (2022). Patent analysis of small molecule therapies. Vol. 68, pp. 102-112.
- Kagaya, T., et al. (2022). Structural-functional correlation in pharmaceutical compounds. Journal of Medicinal Chemistry, 65(3), 1500–1515.
